Welcome to Multibagg AI
Log in to access personalized features
Portfolio
Alerts
Ask Iris
Discovery
Timeline
Multibagg AI is an AI powered stock research and analysis platform. We provide data, information, content, and analytics for publicly traded Indian companies listed on NSE and BSE. AI can make mistakes, check important information.
Prices might be delayed by a few minutes.
Join our Exclusive Community
Join our Exclusive Community
Made with 💙 in India. © Finsky Technologies Pvt Ltd. 2026
Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.
Discovery themes featuring this stock
Resonance Specialities Ltd (RESONANCE) is currently trading at 183.75 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.
Resonance Specialities Limited manufactures and markets Pyridine and Pyridine derivatives, Picoline, and Cyanopyridine, serving industries like pharmaceuticals, chemicals, and agro-chemicals. The company's plant is strategically located in the Tarapur Industrial Zone, providing easy access to resources and distribution channels. Significant recent upgrades include tripling production capacities for Cyanopyridines and enhancing technology with a new fluidized reactor to optimize processes. Partnership with Reilly Chemicals S.A. from Belgium has bolstered the company's production capabilities, particularly in plant upgradation. Innovation in operations, such as the addition of new scrubbers and DG capacity, highlights ongoing efficiency improvements.
Over the past 52 weeks, Resonance Specialities Ltd has traded between a low of ₹77.00 and a high of ₹188.50. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.
Resonance Specialities Ltd has a market capitalization of approximately 201.95. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.
Resonance Specialities Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 13.92 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.
Based on its market capitalization of 201.95 Cr, Resonance Specialities Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.
Resonance Specialities Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.
The Price-to-Earnings (PE) ratio of Resonance Specialities Ltd is 13.92. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.
Resonance Specialities Limited manufactures and markets Pyridine and Pyridine derivatives, Picoline, and Cyanopyridine, serving industries like pharmaceuticals, chemicals, and agro-chemicals.
The company's plant is strategically located in the Tarapur Industrial Zone, providing easy access to resources and distribution channels.
Significant recent upgrades include tripling production capacities for Cyanopyridines and enhancing technology with a new fluidized reactor to optimize processes.
Partnership with Reilly Chemicals S.A. from Belgium has bolstered the company's production capabilities, particularly in plant upgradation.
Innovation in operations, such as the addition of new scrubbers and DG capacity, highlights ongoing efficiency improvements.
Chemicals & Petrochemicals
Specialty Chemicals
202 Cr
Moderate Risk
13.9
39.2
0.5
2.9
188.50
77.00
Sales CAGR
Profit CAGR
ROE
Bearish
8
Neutral
1
Bullish
5
ROCE
Bearish
8
Neutral
1
Bullish
37
Bearish
0
Neutral
0
Bullish
32
| Symbol | Watchlist | Price | Market Cap | P/E | P/B | Div Yield (%) | ROE (%) | ROCE (%) | ROA (%) |
337.95 | 244 Cr | -354.14 | 1.32 | 0.46 | -0.40 | -1.12 | -0.31 | ||
314.95 | 242 Cr | 11.19 | 1.41 | 2.59 | 9.18 | 13.56 | 8.72 | ||
229.05 | 241 Cr | 7.66 | 1.54 | 0.64 | 11.89 | 14.61 | 9.21 | ||
16.48 | 222 Cr | 12.06 | 1.66 | 0.30 | 10.96 | 12.43 | 8.40 | ||
171.15 | 216 Cr | 18.83 | 2.43 | 0.00 | 11.73 | 15.40 | 11.12 | ||
183.75 | 202 Cr | 13.92 | 2.90 | 0.57 | 14.19 | 18.97 | 15.69 | ||
1.04 | 184 Cr | 66.41 | 0.42 | 0.00 | 0.79 | 2.40 | 0.54 | ||
| Median: 7 Co. | — | 183.75 | 222 Cr | 12.06 | 1.54 | 0.46 | 10.96 | 13.56 | 8.72 |
